BEGIN:VCALENDAR
VERSION:2.0
PRODID:ADNA Events System
X-WR-TIMEZONE:America/Toronto
BEGIN:VTIMEZONE
TZID:America/Toronto
X-LIC-LOCATION:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0400
DTSTART:19810329T020000
RRULE:FREQ=YEARLY;INTERVAL=1;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:69e34e3654041
DTSTART;TZID=America/Toronto:20260325T190000
SEQUENCE:0
TRANSP:OPAQUE
DTEND;TZID=America/Toronto:20260325T203000
URL:https://secure.cas.ca/events/index.html/event-info/details/id/65
SUMMARY:CAS SAMBA Round - “Bad Outcomes in Strange Times” Mitochondrial
  DNA Mutation In Specific Patient Population
CLASS:PUBLIC
DESCRIPTION:Approximately 36 healthy patients with Venezuelan ancestry have
  suffered severe neurologic complications\, including stroke and death\, a
 fter routine anesthesia. Cases are most common in South America\, with 8 r
 eported in Europe and 6 in the United States. Anesthesiologists are now ad
 vised to screen for Venezuelan maternal heritage and consider alternative 
 anesthetic plans for at-risk individuals. Join our expert panel to learn h
 ow to prepare when caring for these patients. \n\nhttps://secure.cas.ca/ev
 ents/index.html/event-info/details/id/65
X-ALT-DESC;FMTTYPE=text/html:<p>Approximately 36 healthy patients with Vene
 zuelan ancestry have suffered severe neurologic complications\, including 
 stroke and death\, after routine anesthesia. Cases are most common in Sout
 h America\, with 8 reported in Europe and 6 in the United States. Anesthes
 iologists are now advised to screen for Venezuelan maternal heritage and c
 onsider alternative anesthetic plans for at-risk individuals.&nbsp\;Join o
 ur expert panel to learn how to prepare when caring for these patients.</p
 >\n\n<p>Upon completion of this presentation\, participants will be able t
 o</p>\n\n<p>1.&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;Expl
 ain the genetic basis of mitochondrial-associated hypersensitivity to vola
 tile anesthetics.</p>\n\n<p>2.&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&n
 bsp\;&nbsp\;Describe the screening process and the role of genetic testing
  for identifying patients at risk for mitochondrial- associated hypersensi
 tivity to anesthetics.</p>\n\n<p>3.&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbs
 p\;&nbsp\;&nbsp\;Formulate an anesthetic plan for a patient who screens po
 sitive for mitochondrial-associated hypersensitivity to anesthetics.</p>\n
 \n<p>4.&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;&nbsp\;Discuss str
 ategies for intraoperative monitoring and perioperative clinical decision-
 making of patients who screen positive for mitochondrial-associated hypers
 ensitivity to anesthetics.</p>\n\n<p><strong><em>Note&nbsp\;- Your CAS Mem
 bership must be in good standing for the event date in order to access the
  member discount.&nbsp\;<a href=\"https://secure.cas.ca/access/login.html?
 redirect=https%3A%2F%2Fsecure.cas.ca%2Fmembership%2Frenew.html\" target=\"
 _blank\">Click here to renew</a>.&nbsp\;&nbsp\;</em></strong></p>\n
DTSTAMP:20260418T052614Z
END:VEVENT
END:VCALENDAR